OPIANT PHARMACEUTICALS, INC. Quarterly Interest Expense in USD from Q3 2011 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Opiant Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from Q3 2011 to Q3 2022.
  • Opiant Pharmaceuticals, Inc. Interest Expense for the quarter ending September 30, 2022 was $391K, a 28.6% decline year-over-year.
  • Opiant Pharmaceuticals, Inc. Interest Expense for the twelve months ending September 30, 2022 was $1.72M, a 2.37% decline year-over-year.
  • Opiant Pharmaceuticals, Inc. annual Interest Expense for 2021 was $2.13M, a 1525% increase from 2020.
  • Opiant Pharmaceuticals, Inc. annual Interest Expense for 2020 was $131K.
  • Opiant Pharmaceuticals, Inc. annual Interest Expense for 2019 was $0.000.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $1.72M $391K -$156K -28.6% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $1.87M $401K -$141K -26% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $2.01M $421K -$116K -21.6% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $2.13M $503K +$372K +284% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-15
Q3 2021 $1.76M $547K +$547K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $1.21M $542K +$542K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $668K $537K +$537K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $131K $131K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-15
Q3 2020 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $0 Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $0 Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2015 $5.49K -$13.9K -71.7% Nov 1, 2015 Jan 31, 2016 10-Q 2016-03-15
Q3 2015 $5.83K -$2.38K -29% Aug 1, 2015 Oct 31, 2015 10-Q 2015-12-14
Q4 2014 $56.1K $19.4K +$13.1K +210% Nov 1, 2014 Jan 31, 2015 10-Q 2016-03-15
Q3 2014 $43K $8.21K -$117K -93.5% Aug 1, 2014 Oct 31, 2014 10-Q 2015-12-14
Q2 2014 $160K $21.3K -$99.8K -82.4% May 1, 2014 Jul 31, 2014 10-K 2015-10-26
Q1 2014 $260K $7.25K -$170K -95.9% Feb 1, 2014 Apr 30, 2014 10-Q 2014-06-10
Q4 2013 $430K $6.24K -$103K -94.3% Nov 1, 2013 Jan 31, 2014 10-Q 2015-03-17
Q3 2013 $533K $126K -$19.9K -13.7% Aug 1, 2013 Oct 31, 2013 10-Q 2014-12-09
Q2 2013 $553K $121K +$79.2K +189% May 1, 2013 Jul 31, 2013 10-K 2014-10-27
Q1 2013 $474K $177K +$174K +5806% Feb 1, 2013 Apr 30, 2013 10-Q 2014-06-10
Q4 2012 $300K $109K +$106K +3544% Nov 1, 2012 Jan 31, 2013 10-Q 2014-03-17
Q3 2012 $193K $145K +$132K +977% Aug 1, 2012 Oct 31, 2012 10-Q 2013-12-16
Q2 2012 $61.4K $41.9K May 1, 2012 Jul 31, 2012 10-K 2013-10-29
Q1 2012 $3K Feb 1, 2012 Apr 30, 2012 10-Q 2013-06-14
Q4 2011 $3K Nov 1, 2011 Jan 31, 2012 10-Q 2013-03-18
Q3 2011 $13.5K Aug 1, 2011 Oct 31, 2011 10-Q 2012-12-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.